Unequal global implementation of genomic newborn screening

Studies of genomic newborn screening are highly skewed towards populations in high-income countries. The evidence generated by these studies will be similarly biased and is likely to lead to disparate global implementation. Studies inclusive of historically under-represented populations are needed for equitable global access to genomic newborn screening. In this Comment, Ahmad Abou Tayoun advocates for studies inclusive of historically under-represented populations to ensure equitable global access to genomic newborn screening.

Automated summary

Current studies on genomic newborn screening have a bias towards high-income countries, highlighting the need for inclusive research that represents historically under-represented populations to ensure global equity in access to such screening.